Nisa Investment Advisors’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.3K Buy
237
+42
+22% +$2.39K ﹤0.01% 2311
2026
Q1
$12.5K Sell
195
-3,409
-95% -$311K ﹤0.01% 2160
2025
Q4
$469K Sell
3,604
-14
-0.4% -$1.92K ﹤0.01% 1018
2025
Q3
$390K Buy
3,618
+3,419
+1,718% +$373K ﹤0.01% 1083
2025
Q2
$18.4K Sell
199
-49,961
-100% -$3.92M ﹤0.01% 1984
2025
Q1
$4.44M Buy
50,160
+117
+0.2% +$10.2K 0.02% 439
2024
Q4
$3.85M Buy
50,043
+50,009
+147,085% +$3.49M 0.01% 513
2024
Q3
$1.44K Buy
+34
New +$1.15K ﹤0.01% 2490
2023
Q2
– Sell
-33
Closed – – 2877
2023
Q1
$0 Hold
33
– – ﹤0.01% 2733
2022
Q4
$0 Buy
+33
New +$727 ﹤0.01% 2742

Other funds holding WGS

Nisa Investment Advisors's WGS Position: Q2 2026 in Review

Nisa Investment Advisors increased its GeneDx Holdings (WGS) stake by 22% in Q2 2026, buying an estimated $2.39K and bringing the position to 237 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2311.

Nisa Investment Advisors first reported a position in WGS in Q4 2022 and has held it in 10 quarters since. The position peaked at $4.44M in Q1 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Nisa Investment Advisors held 237 shares of GeneDx Holdings worth $16.3K as of Q2 2026.
  • Nisa Investment Advisors bought 42 GeneDx Holdings shares in Q2 2026, an estimated $2.39K.
  • GeneDx Holdings made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2311 holding.
  • Nisa Investment Advisors first reported a position in GeneDx Holdings in Q4 2022 and has held it in 10 quarters since.
  • Nisa Investment Advisors's GeneDx Holdings position peaked at $4.44M in Q1 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.